HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

ADB-FUBINACA

a synthetic cannabinoid; structure in first source

Also Known As:

N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide

Networked: 4 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Azoles: 2138
    - Pyrazoles: 61
      - Indazoles: 179
        ADB-FUBINACA: 4
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - Indazoles: 179
      - ADB-FUBINACA: 4

Experts

1.	Heckmann, Veronika: 1 article (02/2022)
2.	Kuzma, Mónika: 1 article (02/2022)
3.	Mayer, Matyas: 1 article (02/2022)
4.	Simon, Gábor: 1 article (02/2022)
5.	Tóth, Dénes: 1 article (02/2022)
6.	Brito-da-Costa, Andreia Machado: 1 article (02/2021)
7.	Carmo, Helena: 1 article (02/2021)
8.	Carvalho, Félix: 1 article (02/2021)
9.	Dias-da-Silva, Diana: 1 article (02/2021)
10.	Dinis-Oliveira, Ricardo Jorge: 1 article (02/2021)

Related Diseases

1.	Seizures (Absence Seizure) 12/01/2018 - "Coma, Seizures, Atrioventricular Block, and Hypoglycemia in an ADB-FUBINACA Body-Packer." 02/25/2021 - "ADB-FUBINACA and AMB-FUBINACA display full agonism of the CB1 receptor, this being responsible for their cardiovascular and neurological effects (e.g., altered perception, agitation, anxiety, paranoia, hallucinations, loss of consciousness and memory, chest pain, hypertension, tachycardia, seizures). "
2.	Atrioventricular Block 12/01/2018 - "Coma, Seizures, Atrioventricular Block, and Hypoglycemia in an ADB-FUBINACA Body-Packer."
3.	Myocardial Ischemia (Ischemic Heart Diseases) 02/01/2022 - "Based on the autopsy, histology, and toxicology, it could be reasonably suggested, that ADB-FUBINACA have been a significant contributor to the myocardial ischemia seen in histology. " 02/01/2022 - "A fatal case of myocardial ischemia after ADB-FUBINACA overdose is reported. " 02/01/2022 - "Lethal case of myocardial ischemia following overdose of the synthetic cannabinoid ADB-FUBINACA."
4.	Unconsciousness (Loss of Consciousness) 02/25/2021 - "ADB-FUBINACA and AMB-FUBINACA display full agonism of the CB1 receptor, this being responsible for their cardiovascular and neurological effects (e.g., altered perception, agitation, anxiety, paranoia, hallucinations, loss of consciousness and memory, chest pain, hypertension, tachycardia, seizures). "
5.	Supraventricular Tachycardia 08/01/2017 - "In this case, supraventricular tachycardia was likely the result of exposure to AB-FUBINACA and ADB-FUBINACA. " 08/01/2017 - "To report a case of supraventricular tachycardia and acute confusion after ingestion of e-cigarette fluid containing AB-FUBINACA and ADB-FUBINACA, with quantitative analysis of the serum drug concentrations. " 08/01/2017 - "Supraventricular tachycardia and acute confusion following ingestion of e-cigarette fluid containing AB-FUBINACA and ADB-FUBINACA: a case report with quantitative analysis of serum drug concentrations."

Related Drugs and Biologics

1.	CB1 Cannabinoid Receptor (CB1 Receptor)
2.	Cannabinoids
3.	AB-FUBINACA
4.	methyl 2- (1- (4- fluorobenzyl)- 1H- indazole- 3- carboxamido)- 3- methylbutanoate